Comparative benefits, burdens, and harms of emerging blood-based tests for colorectal cancer screening
The estimated benefits, burdens, and harms of annual blood testing are within the range of current CRC screening strategies. Biennial and triennial testing should also be considered for recommendation given the potential for increased utilization and net population benefit.
Authors
- Aasma Shaukat (ORCID: https://orcid.org/0000-0003-2446-8858)
- Peter S. Liang (ORCID: https://orcid.org/0000-0002-4160-421X)
- Reinier G.S. Meester (ORCID: https://orcid.org/0000-0003-4645-1221)
- Andrew J Piscitello
- Theodore R. Levin (ORCID: https://orcid.org/0000-0002-0842-2377)
- Joseph A Duimstra
Institutions
- Kaiser Permanente (US)
- RED Consulting (Norway) (NO)
- Freenome (United States) (US)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Energetic Materials and Products Incorporation (United States) (US)
- Stanford Medicine (US)
- Empirical Technologies (United States) (US)
- New York University (US)
- Stanford University (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1093/jnci/djaf277
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00